Examining the economic impact of restenosis: implications for the cost-effectiveness of an antiproliferative stentDie wirtschaftlichen Folgen der koronaren Restenose: Einfluss eines antiproliferativ beschichteten Stents auf die Kosteneffektivität

Over the past decade, coronary stenting has been shown to reduce the rates of angiographic and clinical restenosis compared with conventional balloon angioplasty. Despite these improved outcomes, however, coronary stenting is still hampered by a high incidence of restenosis, with important clinical and economic consequences. Recently, the development of antiproliferative, drug-eluting stents has emerged as a promising solution for the primary prevention of restenosis.